Do No Harm: 714X Defying A Hopeless Prognosis
- Regular price
- Sale price
- $24.95 Sale
- Unit price
Adding product to your cart
For a biographical review of this project please scroll down.
THIS AN E-BOOK
NOTICE: WITH THE EXCEPTION OF THIS EDUCATIONAL MATERIAL I DO NOT RECEIVE ANY COMPENSATION FOR ANY OF THE PRODUCTS DISCUSSED.
TO PURCHASE THE PAPERBACK SEE THE LINK BELOW
Gaston Naessens, truly miraculous, 714X should be recognized and included as the foundation of ALL cancer therapy! Why? Because cancer secretes a self-cloaking hormone that makes it invisible to the body.
714X un-locks the natural ability of the body to eliminate the disease-without the dreadful and lethal side effects of the failed conventional allopathic dogma.
Everyone suspects why no cancer cures are "found" is about money, it's much deeper than that, however, isn't it time we awaken from a 100 year mis-leading indoctrination?Our great enemy is fear born of lack of knowledge and it's intentional use against your best interest. 30 Million, Americans died from chemotherapy and radiation in the last 20 years at a cost of TRILLIONS of dollars?
Not entirely our fault, but we allow ourselves to be lulled to sleep by Rockefeller managed medical school indoctrination, propaganda and blockade of viable cancer cures. They demand complete control over our lives.
Also silencing organized refusal to allow insurance companies to cover proven cures from outside pharma control, or the Traditional Healing Arts of Homeopathy, Acupuncture, Naturopathy and others.
WATCH A RECENT INTERVIEW WITH SACHA STONE
Charles Pixley, is a Vietnam Veteran, entrepreneur, who s30 yea ago was at the forefront as a whistleblower fostering the global awakening to congressional, FDA and pharma criminal cabal, publicist for notable authors, as well as a co-author publisher of DO NO HARM: 714x Defy A Hopeless Prognosis, Founder and Chairman, of an Institutional Review Board, IRB, which monitored the protocol a non-toxic cure for cancer and AIDS, which has saved countless lives from certain death
Charles received, notable recognition in numerous magazine articles, has been hosted on 100’s of national and local radio talk shows, interviewed on NBC TV, with famous magazine publisher Bob Guccione, and star of the WALTONS series, Richard Thomas and interviewed by Peter Van Sant for 48 HOURS, and numerous contemporary hosts to speak out against medical crimes against humanity which precipitated government reprisal, wrongful prosecution and incarceration
Today he would like to take us on a time travel dive deep into the Synthesis of Knowledge, the Science of God, source of RE-Awakening to eternal life in Jesus Kingdom and the ever-present enemy of truth and Liar leading only to destruction and death.
Returning home 21 months in Vietnam, awakened to social-political lies and propaganda manipulation intention death profiteers, whose perpetual destruction fosters depravity only to repeat itself in every generation for all time.
Twenty-two year old Charles Pixley swimming against the overwhelming dark current intense focus on What Is Reality? This prayer was soon answered with a surprise appearance of God In Human form. Born-Again, and Angel wings fully functional followed by marriage and 20 years of business pursuits to provide for a growing family.
It’s the dawn of the great awakening for a hypnotized multibillion indoctrinated population. In 1990 his discovery of the Rockefeller cabal and blockade of numerous cures for cancer, AIDS and other degenerative diseases, it invoked an unquenchable rage and commitment to expose and destroy the obvious death for profit gambit. He went on the offense lead by Truth, Knowledge, Power and love, simply stated, God
There were only a handful of others around the world at the time, Dietmar Schildwaechter, MD, PhD., Robert Atkins, MD, G. Edward Griffin, Ed McCabe, “Mr.Oxygen,” , Peter Duesberg, JoStanislaw R. Burzynski MD, PHD, Jon Rappoport, Ralph Moss, PhD, to name a few.
In 1991, Pixley founded and chaired an Institutional Review Board, IRB, under USC Title 21, part 56, and Title 21 Part 50 which mandates "INFORMED CONSENT," for participation or use of any drug.
714X has been available since the late 1960's to understand fully and be empowered read: DO NO HARM: 714X Defying A Hopeless Prognosis! Harmless714X.COM
Rockefeller allopathic indoctrination has set itself up as the arbiter of truth, to destroy all other Healing Arts, since the 1920’s, however during that time numerous proven remedies were shut out of our mainstream by the FDA.
Since the mid 1980's, it was well established in two-major 20-year studies published in major medical journals NEJM, by John Bailar III, MD and the other in LANCET by Michael Spoorn, MD, which proved chemotherapy & radiation are a total failure, and was scientifically proven to have an abysmal 3% survival rate past 5 years.
The FDA could not find anything he had done wrong as we were operating under the aegis of the Federal Code. Nonetheless, they sent an agent to his office every day for days at a time to review our files and take whatever she wanted, and then later raided the office with a dozen armed agents, and stripped files, and soon after seized his car.
The FDA built their illegal indictment based on an AGENCY REGULATION, which was not even a Law, and sought 19 years in prison, after finding that I had brought a small amount of 714X across the border from Canada to rush to a 13-year-old boy, Billy Best.
Pixley had a private meeting with HHS Assistant Secretary Philip R. Lee, MD who had granted me a waiver, this was ignored.
During Federal Court the Judge was summoned to DC for a private meeting with Chief Justice William Rehnquist and President William Jefferson Clinton. Upon his return the next day in court the Judge perfunctorily found me guilty and sentenced me to prison.
At the 2nd Circuit Court of Appeals, he argued Americans have The Right to Life and may preserve their Life by any means available. The 2nd Circuit refused to uphold that Right and upheld District Court decision.
Exactly how many family members, loved ones, friends must die of chemotherapy and radiation before we understand and take charge of our own health and seek out competent non-toxic remedies which remove the threat of death?
The enormous loss to the families and fabric of our nation cost TRILLIONS syphoned from private assets, government, and insurance coffers.
In 1991 Pixley educated the public nationally and internationally about USC TITLE 21 Part 50 and 56 "INFORMED CONSENT." For this he was politically assassinated, sent to federal prison and his live saving book banned for teaching everyone about a proven non-toxic cure for cancer, AIDS and immune disorders called 714X.
Forcing the statute into our consciousness and the bright lights as in November of 2018, President Trump signed into law “THE RIGHT TO TRY ACT!”
We are at the crossroads of 100 years of educational indoctrination, betrayal, and a mind control, hidden within benevolent lies and behind government authority.
Listen to the dynamic and powerful story of conquest and pitfalls of Charles Pixley in his passionate efforts to save lives, with an offensive attack to expose and stop the criminal FDA, Big Pharma, and the Congress they own and control.
Many notable personalities and millions of others around the world over the last 50 years A patron of Pixley’s IRB, Congressman Berkeley Bedell successfully treated for terminal cancer by our Chief Investigator and they both testified before Congress and this sparked a predictable reaction by the FDA.
Most people think or know the FDA has blocked cures, but even if taught alternatives, doctors fear loss of license or worse, the patrons remain terrified from lack of knowledge, insidiously insurance doesn't cover their choices outside Chemo and Radiation.
Recent appearances on Ty and Charlene’s “The Truth About Cancer” series, Dr. Sherry Tenpenny, RedPill78, Mel Fabregas – Veritas Radio, Quite Frankly, Don Jeffries, and Sacha Stone, to name only a few of well over 100 appearances on national and local radio, to include “48 HOURS” with Peter van Sant during the 1990’s.
Since his senseless and illegal incarceration in 1996, over 30 million Americans have died following orthodox therapy! How many more deaths-for-the-profit does that imply for the numbers of dead around the world?
God Bless you. All Rights Reserved without Prejudice
If you prefer you may order the paperback from Amazon.
CANCER and IMMUNE PROFILE BLOOD PANEL
- Regular price
- Sale price
- $0.00 Sale
- Unit price
Adding product to your cart
IF YOU ARE INTERESTED IN THIS BLOOD TEST YOU MUST CONTACT DIRECTLY FOR INSTRUCTIONS and TO ORDER.
American Metabolic Laboratories: https://americanmetaboliclaboratories.com/
Please notice: With the exception of my book
I do NOT receive commissions, nor royalties for any products recommended or discussed.
WHY IS THIS BLOOD PANEL SO VALUABLE AND WHAT WILL IT TELL YOU?
In order to establish a baseline of health and to track progress through the treatment process, a blood test is available which will indicate the presence of primary and metastatic cancer activity, liver function and immune function.
This blood test identifies and quantifies in a highly calibrated, manually conducted test five significant markers, the HCG (human chorionic gonadotropic hormone) by the HCG-beta- chain test, PHI (phosphohexose isomerase), the key enzyme in glycolysis which is greatly increased in cancer cell lines, GGTP for liver function, CEA (carcinoembryonic antigen) and DHEA-S.
The FDA requires an adequate means to monitor and track progression or regression during clinical use of an unapproved substance within the scope of the Institutional Review Board. Beyond these requirements the test allows the following:
- For Prevention of disease:
- Establish an individual's health baseline.
- Determine an individual's immune defense status.
- In established disease:
- Determine activity status, such as primary and secondary in malignant diseases not possible with status quo type scans or MRIs, thus allowing:
- Exact monitoring of response to whatever treatment chosen by treating physician and/or patron, conventional as well as unconventional.
- permits exact and scientific determination of remission in a patron.
- Establishes cures over longer period interval testing.
- Thus, preventing recurrence or relapse of disease.
- For Scientific Clinical Studies and Trials
- Eliminates double blind etc., studies with high degree of inaccuracies (certainly from a true epidemiological scrutiny).
- Eliminates randomized trials.
- Provides early risk factors for malignancies as a true prevention, therefore, complements cancer-search at too late a (clinical) stage with reduced survival chances (Mammography, Colonoscopy, etc.).
- Provides exact clinical-biochemical parameter results for effectiveness of new substances.
- In conjunction with unconventional medical practices.
- Complements Gaston Naessens’ Somatoscopic diagnosis
- Monitors effect of Cell-Milieu-Medicine, fetal tissue therapy, bio-electronic and homeopathic approaches.
Dr. Nieper compares the immune system with the army (which calls out the reserves when there is danger), and the anti-cancer surveillance system with the police whose strength is essentially fixed.
The latter system includes mechanisms for gene repair, and certain steroids such as tumosteron and DHEA. Approximately 60% of all people have sufficient DHEA in their blood to be protected from cancer. Of the remaining 40% about half will develop hidden cancer but not die from it while the rest (20%) will die of diagnosed cancer.
A lack of DHEA has been correlated with peculiarities of the person’s character -- non aggressive, amiable, easily depressed and indecisive.
DHEA-S is produced in the adrenal glands and circulates in the body as DHEA sulfate. A special activation factor, (which possibly is produced in the pineal gland or the thymus gland or the small intestines) changes DHEA-S into free DHEA.
DHEA paralyzes an enzyme (glucose-g-phosphate dehydrogenase) which is of primary importance to the action of cancer cells. This drastically reduces the vitality of the cancer cell and makes it possible for lymphocytes and other white blood cells to overcome the cancer cell.
Dr. Nieper found that during the course of disease, there is a tendency for the DHEA level to gradually decrease, sometimes to values less than 0.1 (100 nano-grams per milliliter). The cancer patient then does not have sufficient starting material to form free DHEA.
There are a number of drugs whose side effects are to cause the level of DHEA-S to drop. Most prominent are the clofibrates that are used to reduce lipid levels. A correlation has been found between higher cholesterol levels in the blood and lower frequency of cancer-if accompanied by higher values of DHEA.
DHEA was isolated by the German Nobelist Butenandt in 1934 and analyzed by the German chemist and Nobelist Windaus. However, the credit for having identified it as an important pillar of our anticancer surveillance system goes to Arthur Schwartz and his coworkers at Temple University in Philadelphia.
A summary of Dr. Hans Neiper's discussion of DHEA from "Revolution in Medicine and Health,"
(Human Chorionic Gonadotropic hormone)
Radioimmunoassay for the HCG-Beta-chain allows the quantitation of minute amounts of human choironic gonadotropic hormone even in the presence of LH, FSH and TSH. The obvious value is the detection of pregnancy within 2-3 days after conception, detection of micro abortion and detection and follow-up of HCG-secreting tumors.
Teratoma, hydatidiform mole and choriocarcinomas in the uterus, ovaries, testes, mediastinum, pineal and pituitary glands, stomach, lungs, esophagus and bladder have long been recognized as trophoblastic HCG-secreting tumors. However, HCG-B has been found in patients with practically all types of malignancies where trophoblasts were not expected:
- testicular, non-trophoblastic gastrointestinal: carcinoid, colonic/rectal, gastric, pancreatic, small intestinal
- hematopoietic: leukemia, all types of lymphomas, multiple myeloma, sarcomas: fibrosarcoma, leiomyosarcoma, osteogenic sarcoma.
- miscellaneous tumors: breast, thyroid, uterine, bladder, adrenal gland, insulinomia, pheochromocytoma
- lung carcinoma
Indeed, it seems that the HCG-secreting trophoblast may play an important role and it may be closely associated with not only embryogenesis but also carcinogenesis. As more data is becoming available, utilizing the sensitive and specific HCG-B test, it becomes evident that the frequency and types of tumors associated with HCG production are much greater than it has been suspected.
Due to the extreme sensitivity of the test (0.0025IU/ml or about 0.2 ng/ml) it is possible to detect, without localization, ongoing malignancies at a very early stage. Once a base level has been established, a patient’s response to therapy can be monitored. The probability of detecting HCG in cancers of all types is, according to the literature surveyed, 10-100%. The longest interval for elevated HCG-B before cancer diagnosis was 26 months.
(Phospho-Hexose Isomerase or glucose phosphate isomerase)
PHI is a key enzyme in glycolysis, i.e. the main anaerobic energy generating step of glucose metabolism. Glycolysis has been observed to become greatly increased in cancer cell lines, hence the measuring of PHI became accepted as a valuable too! in the appraisal of neoplasias.
Elevated PHI levels were found in localized and metastasized cancers of the: bladder, bone, brain, breast, intestines, liver, lungs, lymphosarcoma, melanoma, mouth, head, neck, esophagus, pancreas, prostate, ovary, stomach, colon, rectum and uterus.
PHI has been shown to be elevated in more patients with neoplasia than other enzymes. However, it may not be elevated in the serum of some patients in an early state of neoplasia and indeed, it is not elevated in the serum of some patients with active diseased state. The detection of the enzyme at elevated levels may warrant a more thorough evaluation of the patient.
Once a base level has been established, PHI is a promising enzyme in following the effectiveness of therapy. When, for instance, this enzyme was monitored during treatment of breast cancer, changes in activity followed progression or regression of tumor growth and antedated other laboratory evidence by days or weeks.
It was also found to be indicative of regressions induced by steroids, radio-therapy, oophorectomy, chemotherapy, and hypophysectomy. In cases of confirmed malignancy any elevation or drop, even within the normal ranges, may be significant.
PHI may be elevated in heart, liver and skeletal muscle diseases. Preliminary data indicates that PHI levels parallel CEA results (Personal communications, Miami Heart Institute and Worthington Biochemical Corporation), however, it does not seem to be affected by smoking and it seems to reflect upon a greater variety of diseases. (The performance cost of PHI is about one-half of that of CEA.)
PHI is very abundant in the red blood cells: therefore, it is imperative that the serum specimen is free from hemolysis.
References for HCG:
B.D. Weintraub and S.W. Rosen, Ectopic Production of HCS and HGB by Non-trophoblastic Cancers. J. Clin. Endocr., 13, 94,1971.
- Civantos and A.M. Rywlin, Carcinomas with Trophoblastic Differentiation and Secretion of Chorionic Gonadotropins. Cancer, 29, 789, 1972.
G.D. Braunstein, et al., Ectopic Production of'HCG by Neoplasms. Annals Int. Med., 78, 39, 1973.
A.S. Rabson et al., Production of HCG in vitro by a Cell Line Derived from a Carcinoma of the Lung. J. Natl. Cancer Inst., 50, 669, 1973.
W.S. Floyd and S.L. Cohn, Gonadotropin Producing Hepatoma. Obst. Gyn, 41, 665, 1973.
D.W. Gold et al., Gonadotropin-Secreting Renal Carcinoma. Cancer. 33, 1048,1974.
D.P. Goldstein et al., The clinical Application of Specific RIA for HCG in Trophoblastic and Nontrophoblastic tumors. Surg, Gvnec. Obst., 138. 747, 1974.
D.C. Torney etal., Biological Markers in Breast Carcinoma. Cancer, 35, 1095, 1975.
R.R. Williams et al., Tumor-Associated Antigen Levels Antedating the Diagnosis of Cancer in the Framingham Study. J, Natl. Cancer Inst., 58,1547, 1977.
References for PHI:
- Bodansky, Serum PHI in Cancer: II. As an Index of Tumor Growth in Metastatic Carcinoma of the Breast. Cancer, 7, 1191, 1954.0. Bodansky, Serum PHI in Cancer: III. As an Index of Tumor Growth in Metastatic Carcinoma of the Prostate. Cancer, 8, 1087, 1955.
M.M. Griffith and J.C. Beck, The Value of Serum PHI as an Index of Metastatic Breast Carcinoma Activity. Cancer, 16, 1032. 1963/
M.H. Gault et al., Serum Enzymes in Patients with Carcinoma of the Lung. Canada Med. Assoc. J96,87. 1967.
C.R. Ratliff et al., Serum LDH, PHI and Serological Evidence of Malignant Diseases. Clin. Chem., 16, 527. 1970.
C.R. Ratliff, Serum PHI: A glycolytic Enzyme for Appraising Neoplasia. 4th Ann. So. Calif. Lab. Conference, Anaheim, March 6, 1973.
Worthington Biochemical Corporation, In Case of Malignancy-PHI Monitors Therapy, 1974.